Generic Name: Insulin Aspart 30 Injection

English Name: Insulin Aspart 30 Injection

Chinese Phonetic Symbols: Mendong Yidaosu 30 Zhusheye

Composition: 1ml suspension contains 100 units (100U) of soluble insulin aspart and protamine insulin aspart (equivalent to 3.5mg), with a ratio of 30:70. The active ingredient of the product is insulin aspart (manufactured through gene recombination technology by the using of yeasts).

Indication: UBLIN is indicated for the treatment of diabetes mellitus.

Strength: 3ml: 300 units (cartridge)

Dosage and administration: Individualize and adjust the dosage of UBLIN based on the patient’s medical conditions. This dosage form of the product shall only be used for subcutaneous injection, and shall not be used for intravenous administration, or intramuscular injection. This dosage form of the product cannot be administered using insulin pumps.

Packaging: The cartridge is made of type I glass, with one end sealed by a rubber plunger (bromobutyl rubber) and the other end sealed with a rubber pad (bromobutyl rubber), containing 3ml of suspension liquid within the cartridge. The cartridge has a glass bead inside to help facilitate the homogeneous mixing of the insulin suspension within. One cartridge is packed within each box.

Shelf life: 18 months

Execution standard: YBS00662021

Approval No.: National Drug Approval No. S20210029